Current position
2002-… Associate professor in Public Health – Epidemiology, Biostatistics, Paris-Saclay University
1995-2001 Epidemiologist assistant– MD Public health – INSERM, Hospital Bicetre, Paris-Sud University
Education
1995 Ph.D. Public Health - Epidemiology, Paris-Sud University
1992 Master in Public Health Biostatistics, Paris-Sud University
1995 M.D, Paris-VI Pierre et Mary Curie University, Paris
Responsibilities
2020-… Principal investigator of the EPICOV study (National study on Covid-19 health crisis)
2020-… Deputy director of innovation of the Graduate School of Public Health, Paris-Saclay University
2017-… Director of the Master of Public Health, Paris-Saclay
2005-… Director of M1-Master of Public Health, Paris-Sud-Paris-Saclay
2005 - … Principal Investigator of the outgoing ANRS National French Perinatal Cohorts on HIV prevention of mother-to-child transmission (PMTCT) and on HIV pediatric infection
2010-2019 Principal Investigator of the cohort of adults HIV- infected since childhood: ANRS- Coverte
2009 - … Scientific coordination of immuvirological studies pediatric infection: ANRS- Immip (2009-2012), ANRS-Cleac (2016-2019)
2007- … Scientific coordination of trials on on PMTCT of HIV: ANRS Primeva 2007-13; ANRS Ralfe 2014-18, ANRS Monogest 2016-2020
International Collaborations
2020- Orchestra: Connecting european cohorts to increase common and effective response to SARS-CoV-2 pandemic (Horizon 2020)
2007- Pediacam: HIV pediatric cohort, Cameroon
2011-2015 Eurocoord: Enhancing clinical and epidemiological HIV research in Europe through cohort collaboration y
2006-16 MITOC: Mitochondrial Toxicity in Children and NRTI Exposure During Pregnancy and/or Posnatally. European collaboration
2005-currently: Mother-to-child transmission of HIV: I am the principal investigator (PI) of national ANRS-cohorts on mother to chid transmission which evaluted changes in HIV mother-to-child transmission and efficacy of the mother-to-child prevention strategies (PTME), the safety for mother and non infected neonates of perinatal exposure to HIV antiretroviral therapy ; infection and prognosis in perinatally infected children; transfer to adult medicine and place of disease in the transition to adulthood of young people with chronic diseases since childhood
2020 - currently: I am the PI, with co-scientific responsability (J Warszawski & Nathalie Bajos) of the EpiCov (INSERM and DREES study) which is a national population-based cohort based on a random sample of 134000 participants including in the first round in may 2020, including large questionnaire and systematic covid-19 serology. The objective is to study diffusion on SARS-cov2 in the population and changes of the relation between the Covid-Epidemic in France and health and living condition.